Myrexis Cmn Stk Insiders
MYRXDelisted Stock | USD 0 0.00 0.00% |
Break down of Myrexis Cmn's management performance can provide insight into the company performance.
Jonathan Couchman CEO President CEO, CFO, Director |
Myrexis |
Myrexis Cmn Management Team Effectiveness
The company has return on total asset (ROA) of (0.1506) % which means that it has lost $0.1506 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2567) %, meaning that it created substantial loss on money invested by shareholders. Myrexis Cmn's management efficiency ratios could be used to measure how well Myrexis Cmn manages its routine affairs as well as how well it operates its assets and liabilities.Myrexis Cmn Workforce Comparison
Myrexis Cmn Stk is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 218. Myrexis Cmn adds roughly 1.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Myrexis Cmn Stakeholder
Jonathan Couchman | President CEO, CFO, Director | Profile |
About Myrexis Cmn Management Performance
The success or failure of an entity such as Myrexis Cmn Stk often depends on how effective the management is. Myrexis Cmn management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Myrexis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Myrexis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people.
Please note, the imprecision that can be found in Myrexis Cmn's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Myrexis Cmn Stk. Check Myrexis Cmn's Beneish M Score to see the likelihood of Myrexis Cmn's management manipulating its earnings.
Myrexis Cmn Workforce Analysis
Traditionally, organizations such as Myrexis Cmn use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Myrexis Cmn within its industry.Myrexis Cmn Manpower Efficiency
Return on Myrexis Cmn Manpower
Revenue Per Employee | 0.0 | |
Net Loss Per Employee | 11.6M | |
Working Capital Per Employee | 1.2M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Myrexis Pink Sheet
If you are still planning to invest in Myrexis Cmn Stk check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myrexis Cmn's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |